29 C
Vientiane
Tuesday, September 16, 2025
spot_img
Home Blog Page 468

NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal

NEW YORK, July 28, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal

Ashley Mastronardi delivers the pre-market update on July 28th

  • Stocks are up Monday morning as the U.S struck a trade deal with the EU ahead of President Trump’s August 1st deadline. This deal comes after the U.S reached agreements with Japan and Indonesia last week.
  • The Federal Reserve will hold its next two-day policy meeting on Tuesday and Wednesday. The Central Bank is expected to keep interest rates unchanged, but investors will listen closely to Chair Jerome Powell’s comments.
  • Wall Street will be paying attention to earnings this week as Microsoft, Meta, Amazon and Apple will all report.

Opening Bell
Southside Bancshares (NYSE: SBSI) celebrates the 65th anniversary of Southside Bank

Closing Bell
Seaport Entertainment (NYSE: SEG) celebrates the company’s one-year anniversary

Click here to download the NYSE TV App

Video – https://mma.prnasia.com/media2/2739198/NYSE_Market_Update_July_28.mp4 

 

Big Lake Capital, LLC, Led and Controlled by NMHI CEO, Converts $671,984 Note into Nature’s Miracle (“NMHI”) Common Stocks

ONTARIO, Calif., July 28, 2025 /PRNewswire/ — Nature’s Miracle Holding Inc. (NMHI) (“Nature’s Miracle” or the “Company”), a leader in vertical farming technology announce that Big Lake Capital, LLC (the “Investor”), an investment company led and controlled by CEO Tie “James” Li, converted $678,290 into 3,425,706 NMHI shares at a conversion price of $0.1980 pursuant to the Convertible Promissory Note signed on April 11, 2025, between the Company and Big Lake Capital.

Pursuant to the Convertible Promissory Note signed on April 11, 2025, the Investor is going to lend to the Company up to $2,000,000, with the initial tranche of $600,000 which was funded on April 11, 2025. Terms include an interest rate of 10% payable monthly and a term of one year. The Investor can choose to convert any amount funded plus accrued interest into shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) at a conversion price equal to $0.198 or 110% of the closing price of the Common Stock on April 11, 2025, the date of initial funding. 

Following the conversion, no amounts are outstanding under the note. The Company may borrow up to an additional amount of $1.342.428 under the note.

About Nature’s Miracle Holding Inc.

Nature’s Miracle (www.Nature-Miracle.com) is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture (“CEA”) industry in the U.S. The Company’s Common Stock trades on the OTCQB market (“OTCQB”) under the symbol “NMHI”.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature’s Miracle’s joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature’s Miracle’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature’s Miracle’s ability to develop and launch new products and services; Nature’s Miracle’s ability to successfully and efficiently integrate future expansion plans and opportunities; Nature’s Miracle’s ability to grow its business in a cost-effective manner; Nature’s Miracle’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature’s Miracle’s business model; developments and projections relating to Nature’s Miracle’s competitors and industry; and Nature’s Miracle’s approach and goals with respect to technology.

These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on the OTC; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature’s Miracle’s operates; the risk that Nature’s Miracle’s and its current and future collaborators are unable to successfully develop and commercialize Nature’s Miracle’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature’s Miracle’s is unable to secure or protect its intellectual property; the possibility that Nature’s Miracle’s may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature’s Miracle’s filings from time to time with the SEC.

World’s First Engineered Exosome for Hair Growth & Localized Fat Reduction Secure INCI Designation: ImmVira Accelerates Access to Billion-Dollar Aging-related Market

SUZHOU, China, July 28, 2025 /PRNewswire/ — ImmVira Group (“ImmVira” or the “Company”)recently announced that its engineered exosome products MVR-EX104 (“EX104”, for alopecia treatment) and MVR-EX105 (“EX105”, for localized fat accumulation) have obtained International Nomenclature of Cosmetic Ingredients (INCI) designations following review by the International Cosmetic Ingredient Nomenclature Committee (INC). This dual milestone underscores ImmVira’s breakthrough leadership in functional aesthetic ingredients, bring forward revolutionary consumer healthcare solutions.

Leveraging proprietary OVPENS technology platform, ImmVira developed its engineered exosome portfolio—including MVR-EX103 for skin-related conditions (INCI name granted in April 2025), EX104 for alopecia treatment, and EX105 for localized fat accumulation—for direct commercialization with flexible registration pathways, targeting substantial aging-related market opportunities. Concurrently, on the clinical therapeutic front, our exosome candidates also deliver a novel treatment option for those chronic, hard-to-treat disease indications, such as wound healing and pulmonary fibrosis.

As the universal “passport” for aesthetic ingredients, INCI standards cover multiple major markets including the US, EU, and Japan. This certification validates ImmVira’s pioneering position in engineered exosome technology, enables direct overseas market entry, and enhances consumer trust through INCI’s mandated ingredient transparency.

Per Frost and Sullivan, global alopecia treatment and localized adipose accumulation management treatment markets will reach $89.9 billion and $191.5 billion respectively by 2033. Utilizing engineered exosome that co-delivers multi-functional proteins with designed precise efficacy and enhanced skin penetration, EX104 and EX105 enable deep cellular-level modulation through non-invasive topical use, reshaping traditional treatment paradigms.

“From skin repair (EX103) to hair regeneration (EX104) and localized fat reduction (EX105), our OVPENS platform demonstrates sustainable capacity for breakthrough healthcare innovations. ” stated Dr. Zhou Guoying, CEO of ImmVira. “Leveraging precision-engineered design and targeted delivery of multiplex functional proteins, we maintain a strategically balanced portfolio that directly targets high-value, aging-related market opportunities with strong business acumen. The platform’s inherent expandability allows us to rapidly develop new pipeline candidates to address specific indication needs, enabling novel treatment modalities that empower the public to achieve health and beauty.”

With this dual certification, ImmVira solidifies its role as the global industrial leader in engineered exosomes. ImmVira is accelerating development of a worldwide health and wellness product matrix spanning skin health, hair management and fat reduction, ushering in a new chapter for home-use professional-grade bioactive solutions.

About ImmVira

ImmVira is a global leading clinical-stage biotechnology company that is powered by proprietary biological engineering technology, and is dedicated to the discovery, development, manufacture and commercialization of novel oncolytic immunotherapies and engineered exosome therapies. We have strategically designed and built a risk-balanced product portfolio that comprised both potentially best-in-class oncolytic immunotherapy candidates for solid tumors and innovative engineered exosome assets for clinical application or direct commercialization. Driven by our strategic priority to become a global leader in the full spectrum of bladder cancer treatment development, we have adopted a rationalized, adaptive approach to advance oncolytic immunotherapy candidates with high clinical potential globally. In parallel, leveraging our deep expertise in biological engineering, we have pioneered development of engineered exosome candidates targeting chronic, hard-to-treat diseases as well as age-related conditions. These selected engineered exosome assets are being deliberately accelerated through strategic, differentiated regulatory pathways to enable expedited commercialization and generate sustainable cash flows that will fuel our broader drug development efforts.

Railtown AI Technologies Inc. and AI Partnerships Corp. Partner with Braiyt AI Inc. to Bring Canadian AI Innovation to Dubai and the Middle East

Vancouver, British Columbia – Newsfile Corp. – July 28, 2025 – Railtown AI Technologies Inc. (CSE: RAIL) (OTCQB: RLAIF) (“Railtown” or the “Company”) a leader in Canadian-built artificial intelligence solutions, together with AI Partnerships Corp. (aipartnershipscorp.com), today announced a strategic joint partnership Braiyt AI Inc. (braiyt.ai) to deliver cutting-edge AI technologies to Dubai and the broader Middle East region.

This alliance marks a significant step in expanding the footprint of Canadian AI innovation into one of the world’s most dynamic and rapidly growing markets for artificial intelligence. Under the partnership, Braiyt AI Inc. will act as a regional consultant and service provider, representing Railtown and AIP across Dubai and the Gulf states.

“Braiyt has built a reputation as a trusted Canadian AI solutions provider in the Middle East,” said Cory Brandolini, CEO at Railtown AI Technologies. “Their insight into the regional market, combined with their strong local presence, makes them the ideal partner to help meet the increasing demand for advanced AI capabilities in the region.”

As Middle Eastern organizations continue to pursue digital transformation, the demand for specialized AI solutions has outpaced the capacity of homegrown providers. This partnership ensures that businesses and government agencies across the Gulf can access proven, scalable technologies developed by Canadian innovators.

“Our collaboration with Railtown and AI Partnerships allows us to bring best-in-class AI solutions into a market that is eager for growth and transformation,” said Warsame Ahmed, CEO of Braiyt AI Inc. “We’re proud to be the bridge that connects Canada’s innovation with the Middle East’s bold digital ambitions.”

“The relationship with Braiyt AI, in partnership with Railtown AI Technologies, opens the door and unites our shared vision and complementary strengths to deliver transformative AI solutions to the Middle East,” said Dr. Tom Corr, CEO of AI Partnerships Corp. “By integrating Railtown’s pioneering technology with our global network, we are co-creating a powerful platform for innovation, driving unparalleled value for businesses across diverse markets together.”

“This partnership also opens the door for future collaboration with other members of AI Partnerships Corp.’s growing global network of Affiliates who provide AI based solutions and tools addressing varies vertical market sectors,” said Dr. Tom Corr, CEO of AI Partnerships Corp. “This partnership is another notable example of the AI Partnerships Affiliates leveraging their technical strength and world-wide presence.”

About AI Partnerships Corp.

AI Partnerships Corp. is on a mission to make AI more accessible and affordable to businesses of all sizes. By leveraging the technology and expertise of its Affiliate Network-comprising over 150 AI solutions providers-AI Partnerships supports the mass adoption of enterprise AI globally. Learn more at www.aipartnershipscorp.com.

About Braiyt AI Inc.

Braiyt AI Inc. is a Canadian technology company specializing in delivering next-generation solutions in artificial intelligence, machine learning, and computer vision. Originally founded with a mission to reshape metrics in retail environments, BR[AI]YT has since expanded its capabilities across multiple industries.

The company supports both business and government clients in planning and executing effective AI implementation strategies-whether they’re just beginning their AI journey or enhancing existing capabilities. BR[AI]YT focuses on harnessing the transformative power of AI to create smarter, more efficient, and seamlessly connected physical spaces.

Through innovative, AI-powered solutions, BR[AI]YT aims to enhance operational efficiency, improve user experiences, and drive sustainable growth. With a strong presence in the Middle East and a growing reputation for excellence, BR[AI]YT is on a mission to become the leading force in AI-powered digital transformation in the region and beyond. Learn more at www.braiyt.ai.

About Railtown AI Technologies Inc.

Railtown AI Technologies Inc. (CSE: RAIL) (OTCQB: RLAIF) is a leader in developer productivity tools and agentic frameworks. Based in Vancouver, Canada, Railtown delivers solutions that streamline software development workflows, reduce downtime, and increase the speed of innovation for engineering teams worldwide. By embedding intelligence into every stage of the software lifecycle, Railtown is redefining how modern development teams work. Learn more at www.railtown.ai.

Follow us on social media


SUBSCRIBE FOR INVESTOR NEWS

Click here to receive our latest investor news alerts.

ON BEHALF OF THE BOARD

“Cory Brandolini”
Cory Brandolini, Chief Executive Officer

INVESTOR CONTACT

Rebecca Kerswell
Investor Relations Contact
Email: investors@railtown.ai
Phone: 1-604-417-4440

This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will,” “may”, “should”, “intends”, “anticipates”, “expects” and similar expressions. All statements other than statements of historical fact included in this release, including, without limitation, statements regarding the future plans and objectives of the Company, the commencement of trading of the Company’s common shares on the CSE, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations are risks detailed from time to time in the filings made by the Company with securities regulators.

Readers are cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. As a result, the Company cannot guarantee that any forward-looking statement will materialize, and readers should not place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will only update or revise publicly any of the included forward-looking statements as expressly required by Canadian securities law.

The issuer is solely responsible for the content of this announcement.

Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer’s Association International Conference (AAIC)

Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at International Meeting

FREMONT, Calif., July 28, 2025 /PRNewswire/ — Alamar Biosciences, a company pioneering precision proteomics to drive the earliest detection of disease, today announced the presentation of NULISA™ data in over 30 scientific sessions and poster presentations at the AAIC conference held July 27-31 in Toronto, Canada. The NULISA platform is poised to redefine the landscape of biomarker detection, offering unprecedented sensitivity, specificity and multiplex detection for neurodegenerative disease diagnosis and monitoring. This year’s AAIC marks the first public presentation of robust clinical data generated using NULISA to measure brain-derived pTaus alongside over 120 key CNS disease-related proteins, an achievement that could accelerate both early detection and therapeutic monitoring in Alzheimer’s and related neurodegenerative conditions.

Alzheimer's Association International Conference 2025, Toronto, Canada, July 27-31, 2025.
Alzheimer’s Association International Conference 2025, Toronto, Canada, July 27-31, 2025.

“The presentation of brain-derived pTau data at AAIC is a testament to the power of the NULISA sensitivity and specificity and our team’s dedication to advancing biomarker development for neurodegenerative diseases,” said Yuling Luo, PhD, Founder, Chairman and CEO of Alamar Biosciences.

These data will be presented during Alamar’s product theater on Monday, July 28, 1:20 PM ET, featuring Prof. Jonathan Schott from University College London and the UK DRI, and Dr. Cheryl Wellington from the University of British Columbia. Highlights include:  

  • Brain-Derived pTau Performance: The presentation will showcase data from the 1946 Birth Cohort featuring the new brain-derived pTau isoforms using the NULISAseq™ CNS Disease Panel 120 in both presymptomatic and post-AD diagnosis samples, highlighting the superior ability of brain-derived pTaus to predict Alzheimer’s disease years before it was diagnosed
  • Correlations with Disease Progression: Data will demonstrate the correlation between brain-derived pTau levels and amyloid and Tau PET imaging
  • Biomarkers for neuropathologies and AD co-pathologies: Analysis of a unique cohort of patients with autopsy-confirmed pathologies with the NULISAseq™ CNS Disease Panel 120 identified biomarkers for detecting neuropathologies and AD co-pathologies.
  • Preclinical research: The NULISAseq™ Mouse Panel 120 demonstrated utility in analysis of plasma and brain homogenate samples from multiple clinical models of AD.

The Alzheimer’s Association International Conference (AAIC) is the world’s premier forum for the scientific community focused on dementia and Alzheimer’s research. Every year, the conference gathers leading experts, scientists, clinicians, and stakeholders to share the latest discoveries, foster collaborations, and accelerate the quest for effective diagnostics and therapies.

See here for a full list of posters and presentations featuring NULISA data during the AAIC meeting.

About Alamar Biosciences, Inc.

Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company’s proprietary NULISA Platform along with the ARGO HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com.

-

 

JAS signs SPA to acquire Pentagon Freight Services

ATLANTA, July 28, 2025 /PRNewswire/ — JAS, a global leader in logistics and supply chain solutions, and Pentagon Freight Services (“Pentagon”), a highly specialized integrated Freight Forwarding, Project Logistics and Ships Agency provider headquartered in the UK, are pleased to announce the signing of a Share Purchase Agreement (SPA). This agreement represents a key step toward JAS’s planned acquisition of Pentagon, which is expected to close in the second half of 2025, subject to regulatory approval.

From left, Marco Rebuffi, CEO and President of JAS, and Ashley Taylor, Group CEO of Pentagon.
From left, Marco Rebuffi, CEO and President of JAS, and Ashley Taylor, Group CEO of Pentagon.

“The Pentagon acquisition perfectly complements JAS’s strategic goals, significantly increasing our ability to offer highly specialized logistics solutions for the oil and gas, marine, construction, and energy industries. We are looking forward to finalizing this acquisition to welcome Pentagon team members into the JAS family,” said Marco Rebuffi, CEO and President of JAS. 

“We are confident that JAS is the right company to expand our global network and achieve our growth ambitions. Our goal is to leverage our experience and continue to offer dedicated logistics solutions to our industry-leading clients. We look forward to growing stronger together with JAS,” said Ashley Taylor, Group CEO of Pentagon.

Pentagon, headquartered in the UK, is a trusted provider of specialized freight forwarding, project logistics, and critical supply chain solutions for the oil and gas, energy, marine, and construction industries. With over 1200+ employees in 65 offices around the world, Pentagon’s deep expertise and global reach will further enhance JAS’s ability to deliver tailored, industry-specific solutions. This acquisition will strengthen JAS’s position in these critical sectors, ensuring seamless and high-quality service that keeps complex customer operations moving across the globe.

Together, JAS and Pentagon will unlock new opportunities and deliver even greater value to customers by combining an expanded global network with a comprehensive portfolio of leading logistics solutions.

About JAS
JAS, a global leader in logistics and supply chain solutions, was founded in Milan, Italy, in 1978. Headquartered in Atlanta, Georgia, and supported by 7,000+ team members in more than 100 countries, JAS focuses on creating solutions that are innovative, sustainable, and tailored to customer needs. As a privately owned company, JAS is committed to creating opportunities for communities, customers, and colleagues to thrive.

About Pentagon
Pentagon is a highly specialized global Freight Forwarding, Project Logistics and Ships Agency provider with a worldwide network of over 1200 employees and 65 offices. Headquartered in the UK, Pentagon has more than 50 years’ experience in serving the oil and gas and energy sectors. Pentagon focuses on delivering globally integrated supply chain solutions with local expertise, individually tailored to customers’ operations and requirements.

CreateAI, a Leader in Applied AI Technology, Launches Animon.ai Studio Version for Creators to Make Their Own Anime Series

Animon Studio Makes Professional Anime Creation and Storytelling Accessible to All

TOKYO, July 28, 2025 /PRNewswire/ — CreateAI Holdings (“CreateAI” or the “Company”) (OTC: TSPH), a leader in applied artificial intelligence technology, today announced the launch of the Studio Version of Animon.ai, the world’s first anime-specific AI video generation platform, just three months after its initial debut. Studio Version is a major upgrade that enables individual creators to produce professional-grade anime series with unprecedented efficiency and creative control.

With powerful new tools and features, the Studio Version fully supports every stage of the anime series workflow, focusing on three core aspects of production: high-quality image generation, keyframe consistency, and final shot output—each now enhanced to professional standards to help creators boost productivity, overcome bottlenecks, and unleash creativity.

Start with Stunning Visuals: Generate High-Quality Anime Frames

The Studio Version offers a dedicated image generation model, Aniframe, supporting 2K HD quality, excelling in panoramic, close-up, and detailed scenes. These cover diverse anime styles such as classic Japanese, picture book, line art, pixel, illustration, blind box, ink wash, watercolor, poster design, furry, and engraving, offering the ability to generate up to eight images simultaneously fulfilling a host of project needs. 

Build Narrative Flow: Maintain Character and Scene Consistency with Image Editing Tools

New image-to-image and editing features (e.g., background replacement, pose adjustment, style switching, partial recoloring, and element addition/removal) support multiple aspect ratios and return up to eight images for selection, giving creators greater freedom and control—solving the long-standing challenge of maintaining character consistency across frames.

Bring it to Life: Transform Keyframes into Smooth, Cinematic Video Sequences

Enhanced image-to-video capabilities with the Anicut model series, featuring in-between (first/last frame) generation at 16fps; sharp camera movement control and accurate scene transition editing; and, super-resolution upgrading from 480p / 16fps to 1080p / 24fps. Up to eight videos can be generated simultaneously, significantly improving production efficiency. 

Collaborate and Scale: Studio-Level Tools for Teams and Professionals

Features an immersive collaboration interface, priority computing access, and 24/7 technical and engineering support to streamline team collaboration and ensure seamless creative processes.

“We’re excited to release Animon Studio Version for creators to make their own anime series,” said Cheng Lu, President and CEO of CreateAI. “Animon’s goal is to make the most professional creation tools accessible to all, helping creators overcome resource and efficiency barriers to bring their animation ideas to life.”

Yuji Maruyama, Animon.ai Product Lead, added, “Every Studio Version feature addresses real pain points in anime production. From 2K HD images to precise first/last frame control, we’ve optimized the workflow allowing creators to rapidly generate high-quality assets and videos to make their own anime series.”

Animon.ai is building the world’s first IDE (Integrated Development Environment) for anime series production. Offering unlimited generation from the beginning, the company has steadily evolved its tools and workflows to support creators at every step. The Studio Version is a major milestone in that direction.

Animon.ai Studio Version is now live and available at 49.9 $/month. Creators can try it with a three-day membership for just $0.99. Upcoming features include initial frame presets, scene expansion, and integrated soundtrack tools—bringing creators even closer to a seamless, end-to-end anime production experience.

Animon Media Contact:
pr@animon.ai

About CreateAI 

CreateAI is a global applied artificial intelligence company with offices in the US, China, and Japan. The Company is developing leading AI technology for a number of end-use applications and pioneering the future of digital entertainment content production, seamlessly blending cutting-edge generative AI technology with the creativity of world-class talent. Our mission is to redefine the boundaries of what’s possible in digital storytelling by developing immersive, captivating, and visually stunning experiences that resonate with audiences on a global scale.

CreateAI Media Contact:
Brad Burgess
ICR, LLC
Email: CreateAI.PR@icrinc.com

Octa market outlook: navigating one of the most eventful weeks of the year


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 28 July 2025 – Forex traders are bracing for what could be one of the most pivotal trading weeks of the year. The calendar is packed with high-impact releases that could send shockwaves through the markets, potentially even temporarily halting trading altogether as global economies digest a barrage of critical data. From central bank decisions to blockbuster economic reports, this week is shaping up to be a rollercoaster for volatility, and traders need to be on high alert. Octa Broker is providing an in-depth overview of the week’s key events and actionable insights to help traders navigate this high-stakes environment with confidence.

Octa Broker

A packed calendar: why this week stands out
‘This is one of the busiest weeks I’ve seen in my career,’ says Kar Yong, financial market analyst at Octa Broker. ‘I’ve been in the markets for a long time, and I can genuinely say I’ve rarely witnessed such a major concentration of important events packed into a single week. Traders need to be exceptionally vigilant and prepared for rapid shifts.’

Indeed, this will be a rather heavy week with a massive amount of event risk. It features the crucial U.S. Gross Domestic Product (GDP) report, decisions from three major G7 central banks, including the Federal Reserve (Fed), several key inflation reports, and, arguably the most volatility-inducing event in the Forex calendar, the Nonfarm Payroll (NFP) report. Adding to this potent mix, the International Monetary Fund (IMF) will release its World Economic Outlook on Tuesday, offering a global economic snapshot, while the looming 1 August deadline for U.S. reciprocal tariffs adds a geopolitical wildcard. Furthermore, some of the world’s biggest companies will be reporting their quarterly earnings, particularly Microsoft, Apple, Meta, Amazon, Visa, Mastercard, Procter&Gamble, Hermes, HSBC, Exxon Mobil, and Chevron.

While it’s not unusual for some weeks to carry more weight than others, the upcoming slate of events is exceptional in both volume and significance and suggests a truly historic period for the financial markets.

Here’s a list of some of the major news releases to keep an eye on:

Tuesday, 29 July World IMF World Economic Outlook
United States Trade Balance
United States JOLTS Job Openings
United States CB Consumer Confidence
United States Earnings: Visa
United States Earnings: P&G
Wednesday, 30 July Australia Inflation Rate (CPI)
Eurozone GDP
United States ADP Employment
United States GDP
Canada BoC Interest Rate Decision
United States Fed interest Rate Decision
United States Earnings: Microsoft
United States Earnings: Meta
United States Earnings: Hermes
United States Earnings: HSBC
Thursday, 31 July China NBS Manufacturing and Services PMI
Japan BoJ Interest Rate Decision
Germany Inflation Rate (CPI)
Canada GDP
United States PCE Price Index
United States Earnings: Apple
United States Earnings: Amazon
United States Earnings: Mastercard
Friday, 1 August World U.S. reciprocal tariffs to go into effect
Eurozone Inflation Rate (CPI)
United States NFP
United States ISM Manufacturing PMI
United States Earnings: Exxon Mobil
United States Earnings: Chevron

As you can see, this is an extremely long list that features some heavyweights.

In terms of the top scheduled events, we need to pick and choose what is going to carry the greatest influence. From a global macro perspective, the primary focus is still likely to remain firmly on the ongoing tariff developments. Kar Yong comments: ‘Although the U.S. has recently inked new trade deals with several countries, notably the United Kingdom, Japan, and the Eurozone, the 1 August deadline still looms large for other nations. There remains considerable uncertainty surrounding potential trade resolutions with key economies such as Mexico, Canada, China, South Korea, Taiwan, Brazil, and Singapore, among others. Any headlines or official statements regarding these negotiations could trigger significant market reactions.‘ This tariff tension could weigh heavily on currency pairs like USD/BRL, USD/CNY, and USD/CAD, as markets react to both policy announcements and speculative headlines. Traders should monitor news wires closely, as any breakthroughs—or breakdowns—in trade talks could trigger sharp moves.

Beyond tariffs, the week’s economic calendar is brimming with catalysts:

  • U.S. GDP and Nonfarm Payrolls. The Q2 GDP report on Wednesday will provide a snapshot of U.S. economic health, while Friday’s NFP report could sway expectations for Fed policy. Strong data could bolster the USD, while weaker prints might fuel rate-cut speculation.
  • Central Bank Decisions. The Fed, BoC, and BoJ will announce their interest rate decisions, with markets expecting all three to hold steady. However, forward guidance will be critical, especially from the Fed, as traders parse comments on tariffs and inflation. Jerome Powell’s press conference will be scrutinised for any shifts in monetary policy outlook, especially given the external pressures he is facing from the White House.
  • Inflation Reports. Australia, Germany, and the Eurozone will release Consumer Price Index (CPI) data, which could influence expectations for monetary policy in those regions. The U.S. Personal Consumption Expenditure (PCE) Price Index, the Fed’s preferred inflation gauge, will also be closely watched. Here it will be important to see if record-high inflation expectations (due to rising tariffs) are feeding into the actual CPI figures.
  • China PMI. The NBS Manufacturing and Services PMI will offer insights into China’s economic recovery, a key driver for commodity currencies like AUD and NZD.

How to trade this week: risk management is key
Weeks like these demand a disciplined approach to trading. Volatility can create opportunities, but it also heightens the risk of significant losses. Here’s how Forex traders can navigate this historic week:

  • Stick to what you know. Focus on currency pairs you’re familiar with. Understanding their historical behaviour and key levels will help you make informed decisions amid the chaos.
  • Set stop-losses religiously. Volatility spikes can lead to rapid price swings. Always use stop-loss orders to cap potential losses, and consider tightening them during major releases like NFP or central bank announcements.
  • Limit exposure. Avoid over-leveraging your positions. With so many events, a single unexpected headline could trigger a cascade of stop-outs. Keep position sizes modest to weather potential storms.
  • Stay informed, but don’t chase noise. Follow reliable news sources and economic calendars, but avoid reacting impulsively to every headline. Use tools like Octa’s trading platform, which boasts a proprietary feed of curated expert insights, to stay updated with real-time market data.
  • Diversify risk. Consider hedging strategies or trading less correlated pairs to spread risk. For example, if you’re trading USD pairs, balance exposure with a non-USD pair like EUR/GBP.

The most important takeaway? Stay focused and avoid distractions. The flood of data and headlines can be overwhelming, but successful traders stick to their strategies, trade pairs they understand, and use stop-losses to protect their capital. Emotional decisions in a week like this can lead to costly mistakes.

This week is shaping up to be a historic one for Forex markets. With a dense lineup of economic releases, central bank decisions, and the ongoing tariff saga, traders face both opportunity and risk. By staying disciplined, managing risk effectively, and keeping a close eye on key events, you can navigate this volatile week with confidence.

___

Disclaimer: This press release does not contain or constitute investment advice or recommendations and does not consider your investment objectives, financial situation, or needs. Any actions taken based on this content are at your sole discretion and risk—Octa does not accept any liability for any resulting losses or consequences.
Hashtag: #Octa

The issuer is solely responsible for the content of this announcement.

Octa

is an international CFD broker that has been providing online trading services worldwide since 2011. It offers commission-free access to financial markets and various services used by clients from 180 countries who have opened more than 52 million trading accounts. To help its clients reach their investment goals, Octa offers free educational webinars, articles, and analytical tools.

The company is involved in a comprehensive network of charitable and humanitarian initiatives, including improving educational infrastructure and funding short-notice relief projects to support local communities.
In Southeast Asia, Octa received the ‘Best Trading Platform Malaysia 2024’ and the ‘Most Reliable Broker Asia 2023’ awards from Brands and Business Magazine and International Global Forex Awards, respectively.